Page last updated: 2024-11-02

oxidopamine and Anoxia, Brain

oxidopamine has been researched along with Anoxia, Brain in 2 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dajas-Bailador, FA1
Martinez-Borges, A1
Costa, G1
Abin, JA1
Martignoni, E1
Nappi, G1
Dajas, F1
Sahach, VF1
Baziliuk, OV1
Oleshko, MM1
Kotsiuruba, AV1
Appenzeller, O1

Other Studies

2 other studies available for oxidopamine and Anoxia, Brain

ArticleYear
Hydroxyl radical production in the substantia nigra after 6-hydroxydopamine and hypoxia-reoxygenation.
    Brain research, 1998, Nov-30, Volume: 813, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Hydroxybenzoates; Hydroxyl Radical; Hydroxylation

1998
[The nitrous oxide system under conditions of chronic cerebral dopamine deficiency and hypoxia].
    Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994), 1999, Volume: 45, Issue:1-2

    Topics: Animals; Aorta; Dopamine; Heart; Hypoxia, Brain; Male; Muscle, Smooth, Vascular; Myocardium; Neostri

1999